Erin Michos to Fibroblast Growth Factors
This is a "connection" page, showing publications Erin Michos has written about Fibroblast Growth Factors.
Connection Strength
0.720
-
Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study. Am J Hypertens. 2019 01 01; 32(1):18-25.
Score: 0.177
-
Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA. J Am Heart Assoc. 2018 09 18; 7(18):e008334.
Score: 0.173
-
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. J Am Soc Nephrol. 2018 10; 29(10):2583-2592.
Score: 0.173
-
Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function. J Clin Endocrinol Metab. 2017 04 01; 102(4):1387-1395.
Score: 0.156
-
Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab. 2017 12 01; 102(12):4648-4657.
Score: 0.041